OMTH News
Archived Headlines
- 7 US IPOs planned for the week of Apr 8 04/08/13
- US IPO Recap: 9 set terms, 8 file as market springs to life 04/08/13
- Four IPOs set terms as April's US IPO calendar quickly builds 04/01/13
- Biotech Omthera Pharmaceuticals sets terms for $75 million IPO 04/01/13
- US IPO Weekly Recap: Calendar quickly builds, Silver Spring jumps in debut 03/17/13
See more
Biotech IPOs are back to normal
By almost any measure, 2013 has been a record-breaking year for biotech IPOs. The 33 biotech IPOs completed and the $2.5 billion raised are more than the totals from the previous five years combined and far exceed the levels reached at the height of the tech...read more
US IPO Recap: Six deals price in another strong week for filings
Led by two large deals from Puerto Rican transaction processor EVERTEC (EVTC) and homebuilder Taylor Morrison (TMHC), six US IPOs raised a total of more than $1.5 billion last...read more
Chimerix stock soars as two biotechs debut Thursday
Two biotechs, Chimerix (CMRX) and Omthera Pharmaceuticals (OMTH), debuted on Thursday, bringing the total to five deals that have priced in April. Chimerix finished the day up 34.2% and Omthera traded down 7.1%. The companies joined...read more
Omthera Pharmaceuticals prices upsized IPO below the range at $8
Omthera Pharmaceuticals, which has developed a prescription fish oil capsule that reduces triglyceride levels, raised $64 million by offering 8.0 million shares at $8, well below the range of $12 to $14. Omthera, which initially filed confidentially on 1/25/2013...read more